Signe Borgquist Selected Research

Biomarkers (Surrogate Marker)

5/2022	Aquaporin-5 in breast cancer.
1/2022	Aquaporin-1 in breast cancer.
12/2021	Local Biomarkers Involved in the Interplay between Obesity and Breast Cancer.
9/2021	High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer.
3/2021	Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients.
1/2021	Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression.
11/2020	CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients.
1/2017	Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort.
9/2016	High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer.
1/2016	Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Signe Borgquist Research Topics

Disease

107	Breast Neoplasms (Breast Cancer) 03/2024 - 11/2005
86	Neoplasms (Cancer) 03/2024 - 11/2005
15	Obesity 10/2023 - 09/2008
7	Neoplasm Metastasis (Metastasis) 03/2024 - 09/2009
4	Lymphoma (Lymphomas) 03/2017 - 07/2014
3	Carcinogenesis 06/2023 - 07/2010
3	Overweight 11/2022 - 09/2009
3	Inflammation (Inflammations) 08/2022 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 06/2016 - 04/2010
2	Hypercholesterolemia 01/2020 - 04/2017
2	Hypoxia (Hypoxemia) 01/2020 - 11/2008
2	Leukemia 01/2018 - 03/2013
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 06/2016
2	Endometrial Neoplasms (Endometrial Cancer) 01/2017 - 07/2010
2	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2015 - 09/2014
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2014 - 07/2014
2	Microsatellite Instability 04/2014 - 11/2013
2	Meningioma (Meningiomas) 09/2011 - 10/2010
1	Vaginal Discharge 01/2023
1	Hot Flashes 01/2023
1	Muscle Cramp (Cramp) 01/2023
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 07/2022

Drug/Important Bio-Agent (IBA)

29	Estrogen ReceptorsIBA 03/2024 - 11/2008
20	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2022 - 09/2008
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2008
14	Hormones (Hormone)IBA 10/2023 - 09/2009
14	Biomarkers (Surrogate Marker)IBA 05/2022 - 05/2014
11	Tamoxifen FDA LinkGeneric 03/2024 - 12/2009
9	Estrogens (Estrogen)FDA Link 12/2021 - 05/2007
8	LipidsIBA 02/2022 - 06/2016
7	Atorvastatin (Lipitor)FDA Link 11/2020 - 04/2013
7	Cyclin D1IBA 08/2015 - 01/2007
6	CholesterolIBA 07/2022 - 04/2015
6	Oral ContraceptivesIBA 01/2020 - 07/2010
6	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 01/2008
6	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2015 - 01/2008
5	Estrogen Receptor alphaIBA 01/2021 - 11/2008
5	Estrogen Receptor betaIBA 02/2013 - 11/2008
4	Aromatase InhibitorsIBA 11/2023 - 04/2017
4	Phenobarbital (Luminal)FDA Link 01/2023 - 06/2015
4	Vitamin D FDA LinkGeneric 08/2022 - 09/2014
4	Insulin (Novolin)FDA Link 08/2022 - 01/2017
4	ORALIT (ORS)IBA 12/2021 - 03/2017
4	Messenger RNA (mRNA)IBA 11/2021 - 11/2008
4	EnzymesIBA 09/2021 - 01/2008
4	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021 - 04/2010
4	AntibodiesIBA 01/2020 - 01/2015
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 01/2011
4	Androgen Receptors (Androgen Receptor)IBA 10/2017 - 08/2014
3	Caveolin 1IBA 06/2023 - 01/2020
3	SeleniumIBA 06/2022 - 01/2020
3	27-hydroxycholesterolIBA 09/2021 - 01/2017
3	CAP1-6DIBA 01/2021 - 01/2018
3	AdipokinesIBA 01/2021 - 01/2018
3	Mevalonic Acid (Mevalonate)IBA 11/2020 - 01/2008
3	HDL CholesterolIBA 09/2019 - 06/2016
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2023 - 01/2021
2	Calcitriol Receptors (Calcitriol Receptor)IBA 08/2022 - 01/2019
2	LDL Receptors (LDL Receptor)IBA 07/2022 - 11/2020
2	ZincIBA 06/2022 - 09/2021
2	Aquaporin 5IBA 05/2022 - 12/2021
2	ApolipoproteinsIBA 02/2022 - 06/2016
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2022 - 06/2016
2	Apolipoproteins B (ApoB)IBA 02/2022 - 06/2016
2	Thyroid HormonesIBA 12/2021 - 08/2015
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 12/2021 - 08/2015
2	Insulin-Like Growth Factor Binding ProteinsIBA 11/2021 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2018
2	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2021 - 02/2017
2	Insulin-Like Growth Factor Binding Protein 3IBA 01/2021 - 04/2010
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2021 - 01/2020
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 04/2010
2	ParaffinIBA 11/2020 - 04/2015
2	human ERBB2 proteinIBA 08/2020 - 04/2015
2	ResistinIBA 01/2020 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 09/2019 - 01/2018
2	SteroidsIBA 01/2018 - 01/2017
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2018 - 08/2015
2	Insulin-Like PeptidesIBA 01/2018 - 03/2017
2	Iodide Peroxidase (Deiodinase)IBA 01/2018 - 08/2015
2	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2018 - 09/2008
2	Insulin ReceptorIBA 02/2017 - 01/2017
2	oxidized low density lipoproteinIBA 06/2016 - 01/2016
2	CalciumIBA 09/2014 - 09/2009
2	Small Interfering RNA (siRNA)IBA 12/2009 - 11/2008
2	Cyclin EIBA 01/2007 - 11/2005
1	Glucose (Dextrose)FDA LinkGeneric 03/2024
1	16-fluoroestradiolIBA 03/2024
1	AntioxidantsIBA 12/2023
1	Dihydrotachysterol (AT 10)IBA 10/2023
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2023
1	Phosphorus (Red Phosphorus)IBA 06/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2022

Therapy/Procedure

15	Therapeutics 03/2024 - 01/2009
6	Neoadjuvant Therapy 06/2022 - 12/2019
4	Radiotherapy 01/2022 - 09/2014
4	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2018 - 05/2007
3	Adjuvant Chemotherapy 06/2023 - 02/2017
2	Drug Therapy (Chemotherapy) 11/2023 - 02/2017
1	Oral Administration 01/2022